Brian Lenz
2023 - ADMA Biologics
In 2023, Brian Lenz earned a total compensation of $2M as Former Executive Vice President and Chief Financial Officer at ADMA Biologics, a 23% increase compared to previous year.
Compensation breakdown
| Bonus | $334,875 |
|---|---|
| Option Awards | $595,607 |
| Salary | $475,000 |
| Stock Awards | $452,836 |
| Other | $107,042 |
| Total | $1,965,360 |
Lenz received $595.6K in option awards, accounting for 30% of the total pay in 2023.
Lenz also received $334.9K in bonus, $475K in salary, $452.8K in stock awards and $107K in other compensation.
Rankings
In 2023, Brian Lenz's compensation ranked 532nd out of 2,918 executives tracked by ExecPay. In other words, Lenz earned more than 81.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 532 out of 2,918 | 82nd |
Division Manufacturing | 306 out of 1,608 | 81st |
Major group Chemicals And Allied Products | 214 out of 901 | 76th |
Industry group Drugs | 211 out of 864 | 76th |
Industry Biological Products, Except Diagnostic Substances | 74 out of 211 | 65th |
Source: SEC filing on April 15, 2024.
Lenz's colleagues
We found one more compensation record of an executive who worked with Brian Lenz at ADMA Biologics in 2023.
2023
Adam Grossman
ADMA Biologics
Chief Executive Officer
News
ADMA Biologics CEO Adam Grossman's 2023 pay jumps 128% to $6M
April 15, 2024
ADMA Biologics CEO Adam Grossman's 2022 pay falls 39% to $2.6M
April 13, 2023
ADMA Biologics CEO Adam Grossman's 2021 pay jumps 122% to $4.4M
April 28, 2022
ADMA Biologics CEO Adam Grossman's 2020 pay rises 15% to $2M
April 7, 2021
ADMA Biologics CEO Adam Grossman's 2019 pay rises 10% to $1.7M
April 29, 2020
ADMA Biologics CEO Adam Grossman's 2018 pay falls 42% to $1.6M
April 24, 2019